Header Logo

Connection

DAVID ALLISON to Glucagon-Like Peptides

Back to Details
This is a "connection" page, showing publications DAVID ALLISON has written about Glucagon-Like Peptides.
DAVID ALLISON
Connection Strength
0.926
Glucagon-Like Peptides
  1. Real-World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study. Obesity (Silver Spring). 2026 Mar; 34(3):729-737.
    View in: PubMed
    Score: 0.926
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.